Most Popular
-
1
Ador CEO denies allegations, accuses Hybe of mistreating NewJeans
-
2
Medical reform committee kicks off despite boycott from doctors
-
3
10-man S. Korea lose to Indonesia to miss out on Paris Olympic football qualification
-
4
Hybe-Ador feud should have limited effect on Hybe's overall performance: analysts
-
5
DP leader says he will meet Yoon without conditions
-
6
Over 9,000 hotline calls made by stalking victims in 2023
-
7
Second Gimpo civil servant found dead, after apologizing for not finishing work
-
8
[Hello India] Hyundai Motor vows to boost 'clean mobility' in India
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/25/20240425050672_0.jpg&u=)
-
9
Monthly users on local streaming platforms outpace Netflix, Disney+
-
10
US will take steps for three-way engagement on nuclear deterrence with S. Korea, Japan: Campbell
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/25/20240425050672_0.jpg&u=)
Celltrion unveils W100b buyback plan to stabilize stock prices
By YonhapPublished : Jan. 10, 2022 - 16:07
Its affiliate, Celltrion Healthcare, which handles overseas business operations, will also repurchase 50 billion won of its shares.
The buyback plans are scheduled to start Jan. 11 and run until April 10, the companies said, adding their boards of directors made the decisions.
Currently, Celltrion owns 1.32 million shares, and Celltrion Healthcare holds 1.73 million shares. (Yonhap)
